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Generation of CD8+ memory T cells requires meta-
bolic reprogramming that is characterized by
enhanced mitochondrial fatty-acid oxidation (FAO).
However, where the fatty acids (FA) that fuel this pro-
cess come from remains unclear. While CD8+ mem-
ory T cells engage FAO to a greater extent, we found
that they acquired substantially fewer long-chain FA
from their external environment than CD8+ effector T
(Teff) cells. Rather than using extracellular FA
directly, memory T cells used extracellular glucose
to support FAO and oxidative phosphorylation (OX-
PHOS), suggesting that lipids must be synthesized
to generate the substrates needed for FAO. We
have demonstrated that memory T cells rely on cell
intrinsic expression of the lysosomal hydrolase LAL
(lysosomal acid lipase) to mobilize FA for FAO and
memory T cell development. Our observations link
LAL to metabolic reprogramming in lymphocytes
and show that cell intrinsic lipolysis is deterministic
for memory T cell fate.
INTRODUCTION
Upon infection, activated CD8+ T cells undergo a distinct pattern
of differentiation characterized by the proliferation of antigen
(Ag)-specific effector T (Teff) cells, followed by contraction of
these cells and development of long-lived memory T cells (Cui
and Kaech, 2010; Harty and Badovinac, 2008). During this pro-
cess, T cells metabolically reprogram to provide for the divergent
energetic and functional needs of these distinct cell types. Teff
cells, which require precursors for biomass accumulation and
effector functions, dramatically increase aerobic glycolysis
(Caro-Maldonado et al., 2012), whereas memory T cells use
oxidativephosphorylation (OXPHOS) tomeetmetabolicdemands
(van derWindt and Pearce, 2012). Although Teff cells can engage
OXPHOS (Chang et al., 2013; Wang et al., 2011), which is neces-sary for their Ag driven proliferation (Sena et al., 2013), memory
T cells rely on this metabolic pathway, and in particular, the use
of fatty acids (FA) to fuel this process (Pearce et al., 2013).Wepre-
viously demonstrated that fatty-acid oxidation (FAO) provides a
metabolic advantage for the survival of memory T cells and for
their rapid recall after reinfection (van der Windt et al., 2012; van
der Windt et al., 2013). However, how memory T cells access
FA to fuel this process remains unclear.
There is a strong association between burning fat and living
longer (Hansen et al., 2013; Wang et al., 2008). Memory T cells
are long-lived and previous studies demonstrating that they
engage FAO to support survival have helped establish the link
between lipid metabolism and cellular longevity in the immune
system (Pearce, 2010; van der Windt et al., 2012). Given that
long-lived lymphocytes are a goal of vaccination, there is interest
in understanding the pathways that regulate their longevity.
Lipolysis is the hydrolysis of stored lipids to liberate FA that
can then be used as energy substrates, essential precursors
for membrane synthesis, or signaling mediators (Farese and
Walther, 2009; Lass et al., 2011; Zechner et al., 2012). Consistent
with the importance of lipolysis in energy homeostasis, it is
thought to occur in all cell types, but is most abundant in adipose
tissue, where the release of stored fats into the vasculature sup-
plies energy substrates to other cells (Lass et al., 2011; Zechner
et al., 2012). Several enzymes and regulatory factors, such as
adipose triglyceride lipase (ATGL) and hormone-sensitive lipase
(HSL), regulate the release of lipids from lipid droplets in
response to changes in the nutritional state (Brasaemle, 2007;
Farese and Walther, 2009). Other lipases, such as lysosomal
acid lipase (LAL) can also contribute to lipolytic processes
(Sheriff et al., 1995). Tissues around the body that use FAO,
such as cardiac and skeletal muscle, liver, and kidney, can ac-
quire FA from the blood and oxidize them in mitochondria to
fuel energy production (Kodde et al., 2007; Reddy and Rao,
2006; Weinberg, 2011; Zhang et al., 2010). While lipolysis in adi-
pocytes has been extensively studied, how other cells store, ac-
cess, ormobilize FA is lesswell understood (Zechner et al., 2012).
We show that although CD8+ memory T cells depend on FAO
(van der Windt et al., 2012), they do not acquire appreciable
amounts of extracellular free FA to fuel this process, and in
contrast to Teff cells, do not readily store exogenous long-chainImmunity 41, 75–88, July 17, 2014 ª2014 Elsevier Inc. 75
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Figure 1. Unlike CD8+ Teff Cells, CD8+ Memory T Cells Do Not Acquire Substantial Amounts of Extracellular Fatty Acids
OT-I cells were injected i.v. into congenic recipients. Mice were infected with LmOVA to generate Teff (TE; 7 days) and memory T (TM; R21 days) cells, and
peripheral blood was collected 1 hr after i.v. Bodipy FL C16 injection and uptake quantified by FACS.
(A) Representative plots (histogram) and average MFI (bar graph) of Bodipy FL C16 in Teff and memory T K
bOVA-specific CD8+ OT-I+ cells from two experiments
(n = 7-8 mice/group). Error bars show mean ± SEM, **p < 0.01.
(legend continued on next page)
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Lysosomal Lipolysis in CD8+ Memory T CellsFA in lipid droplets. Instead, memory T cells use extracellular
glucose to support FAO andOXPHOS, indicating that these cells
synthesize FA for mitochondrial FAO. Consistent with the reli-
ance of memory T cells on FAO, LAL, an enzyme that hydrolyzes
cholesterol esters (CE) and triacylglycerol (TAG) to generate free
FA and cholesterol in the lysosomes of cells (Sheriff et al., 1995),
is expressed in CD8+memory T cells and supports themetabolic
reprogramming necessary for their development.
RESULTS
Unlike Teff Cells, Memory T Cells Do Not Acquire
Substantial Amounts of Extracellular FA
Because memory T cells use long-chain FA to fuel FAO (van der
Windt et al., 2012), we investigatedwhether these cells, like other
cells that use FAO, acquire free FA from their external environ-
ment (Kiens, 2006; Koonen et al., 2005). To this end, we isolated
CD8+ T cells from OT-I transgenic mice and transferred
them into congenic recipients and then infected the mice with
Listeria monocytogenes expressing ovalbumin (OVA) (LmOVA)
to induce an OVA-specific CD8+ T cell response. We then in-
jected, fluorescently labeled palmitate (Bodipy FL C16), a long-
chain FA, into the mice 7 days (Teff phase) or 21 days (memory
T phase) after LmOVA infection. One hour after Bodipy FL C16 in-
jection, OVA-specific donor T cells were analyzed for FA uptake.
OVA-specific CD8+ memory T cells acquired significantly less
palmitate compared to OVA-specific CD8+ Teff cells (Figure 1A).
There was no difference in Bodipy FL C16 uptake between
KLRG-1hi and KLRG-1lo Ag-specific Teff cells (Sarkar et al.,
2008), indicating that increased FA uptake is not specific to
short-lived Teff cells, but to Teff cells as a whole (data not
shown). Since Bodipy FL C16 was injected at distinct time points
to assess differences in FA acquisition between Teff and mem-
ory T cells, we also compared cells within an individual animal.
We injected Bodipy FL C16 7 days postinfection and 1 hr later
assessed its incorporation into CD8+ CD44hiCD62Llo Teff cells,
and into CD8+ T cells expressing naive (Tn; CD44loCD62Lhi) or
memory T (CD44hiCD62Lhi) markers (Figure 1B, histogram
only). We observed the same trend in these polyclonal T cells
as compared to day 7 Teff cells and to memory T cells and to
T cells expressing Tn markers day 21 postinfection, because
memory T cells took up less palmitate than Teff cells (Figure 1B,
bar graph). Although acquisition by memory T cells appeared
higher than Tn cells, the difference was not statistically signifi-
cant. Consistent with Teff cells acquiring more Bodipy FL C16
than memory T cells, secondary CD8+ Teff cells (2 Teff) from(B)Representativeplots (histogram)ofBodipyFLC16MFI inpolyclonal Teff (CD44
h
7 days postinfection and averageMFI (bar graph) of polyclonal CD8+ T cells from t
(C) OT-I cells were activated with OVA peptide and IL-2 for 3 days and subsequen
Teff cells, respectively.
(D) OT-I cells were incubated with Bodipy FL C16 on days 4–7 of culture, and uptak
from three experiments is shown as mean ± SEM, *p < 0.05 by one-sample t tes
(E) CD36 expression on day 7 IL-2 Teff and IL-15 memory T cells, or polyclonal T
(F–H) Day 6 IL-2 Teff or IL-15 memory T cells were cultured overnight ± oleate th
average Bodipy MFI from three experiments show mean ± SEM, *p < 0.05, **p
periments. Scale bars represent 2 mM.
(I) OT-I cells expressing a lipid droplet-targeting construct (LD-GFP) were cultured
two experiments.
(J) Cells were incubated with Bodipy-LDL or left unstained (control), data represmice challenged with LmOVA 4 days prior exhibited increased
Bodipy FL C16 uptake relative to memory T cells (see Figure S1A
available online). Polyclonal Teff cells from these mice, which
were comparable in size to memory T cells, also acquired
more Bodipy FL C16 (Figure S1A), indicating that differences in
FA acquisition are not only due to cell size differences.
To further investigate FA acquisition we stimulated CD8+ OT-I
cells with OVA peptide and interleukin-2 (IL-2) for 3 days, then
differentially cultured the cells in IL-2 or IL-15 for 4 more days
(Figure 1C) to approximate in vitro the conditions that program
CD8+ Teff and memory T cells, respectively, after infection
(Carrio et al., 2004; van der Windt et al., 2012). Like our in vivo
findings, IL-15 differentiated memory-like T (IL-15 memory T)
cells acquired much less Bodipy FL C16 than IL-2 driven
effector-like (IL-2 Teff) cells (Figure 1D). As IL-2 Teff cells differ-
entiated into IL-15 memory T cells, their ability to acquire Bodipy
FL C16 decreased. Following overnight incubation with Bodipy
FL C16, the difference in uptake between IL-2 Teff and IL-15
memory T cells remained (Figure S1B). Surface expression
of CD36, a receptor that binds long-chain FA and low-density
lipoprotein (LDL) (Silverstein and Febbraio, 2009), was lower on
IL-15 memory T cells and on in vivo generated memory T cells
compared to their Teff cell counterparts (Figure 1E), consistent
with their reduced capacity to acquire FA.
Given the difference in FA uptake between these cells, we
assessed their total neutral lipid (indicates stored fat). IL-2 Teff
cells stained with unconjugated Bodipy had more neutral lipid
than IL-15 memory T cells (Figure 1F), and when incubated
with the long-chain FA oleate, only IL-2 Teff cells exhibited an in-
crease in Bodipy staining (Figures 1F and 1G). Furthermore, IL-2
Teff cells cultured with oleate formed lipid droplets (Figure 1H).
These structures were not evident in IL-15 memory T cells. Sup-
porting these observations, Tip47, a lipid droplet protein (Bulan-
kina et al., 2009), was expressed more in IL-2 Teff than IL-15
memory T cells (Figure S1C). To confirm that these structures
were lipid droplets, we transduced T cells with a retrovirus con-
taining a lipid droplet-targeting construct (LD-GFP), where GFP
was fused to the N-terminal hydrophobic region of METTL7B
(ALDI), a protein that localizes to lipid droplets (Zehmer et al.,
2008), and differentially cultured them in IL-2 or IL-15. LD-GFP
localized to lipid droplets in IL-2 Teff cells, which became abun-
dant in oleate-supplemented IL-2 Teff cells (Figure 1I). In
contrast, the IL-15 memory T cells exhibited diffuse fluores-
cence, even when supplemented with oleate. We interpret
the diffuse fluorescence to indicate retroviral expression of
METTL7B-GFP in the cytoplasm. These data show that unlikei CD62Llo),memoryT (CD44hiCD62Lhi), andTn (TN;CD44
loCD62Lhi) CD8+Tcells
wo experiments (n = 9 mice/group). Error bars showmean ± SEM. ***p < 0.001.
tly cultured in IL-15 or IL-2 for 4 more days to generate IL-15memory T and IL-2
e was measured. MFIs were normalized to the daily MFI of IL-2 Teff cells. Data
t.
cells. Data represent three experiments.
en stained with Bodipy. (F) Representative plots showing Bodipy MFI and (G)
< 0.01. (H) Images showing Bodipy (green) and CD8 (red) represent four ex-
overnight ± oleate. Images show LD-GFP (green) and CD8 (red) and represent
ent two experiments.
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Figure 2. Ultrastructure Analysis Reveals Densely Packed Mito-
chondria in Close Proximity to ER in Memory T Cells
EM images of mitochondria associated with ER from (A) Teff and memory
T cells and (B) IL-2 Teff and IL-15 memory T cells; mitochondrion, red arrow;
ER, blue arrow; electron dense structure, green arrow. Data represent R2
experiments.
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Lysosomal Lipolysis in CD8+ Memory T CellsIL-15 memory T cells, IL-2 Teff cells acquire long-chain FA and
store them as neutral lipid (e.g., TAG and CE) in lipid droplets.
We questioned whether memory T cells are able to acquire
other forms of lipid produced in vivo, such as those that provide
cholesterol. We added Bodipy-conjugated LDL in vitro and
found that IL-15 memory T cells acquired LDL, although to a
lesser extent than IL-2 Teff cells (Figure 1J). In addition, Tn, as
well as Teff and memory T cells, acquired LDL to a somewhat
similar extent in vivo (Figure 1J), a pattern distinct from what
we observed for Bodipy FL C16. These data, and those shown78 Immunity 41, 75–88, July 17, 2014 ª2014 Elsevier Inc.in Figures 1A and 1B, indicate that different T cells exhibit distinct
preferences for lipid substrates, suggesting that acquisition
of lipids that provide cholesterol for membranes and other pro-
cesses might be different from those that fuel energy meta-
bolism, fitting with published data (Bensinger et al., 2008; Kidani
et al., 2013).
Glucose Fuels Mitochondrial FAO and OXPHOS in IL-15
Memory T Cells
We did not visualize abundant lipid droplets by electron micro-
scopy (EM) in either Teff or memory T cells. We did, however,
observe accumulations of mitochondria in close association
with endoplasmic reticulum (ER) in memory T cells, but not Teff
cells (Figures 2A and 2B). Furthermore, we observed electron-
dense structures localized to mitochondria and ER in IL-15
memory T cells (Figure 2B), which were always proximal to mito-
chondria and did not appear in other areas of the cytoplasm.
Lipids imported into the mitochondria can be synthesized in
the ER, requiring an interaction between these two compart-
ments (Flis and Daum, 2013), and glycerol-3-phosphate acyl-
transferases, critical enzymes for glycerolipid synthesis and
ultimately TAG production, can associate with ER andmitochon-
dria (Wendel et al., 2009). Given that memory T cells engage FAO
to fuel OXPHOS (van der Windt et al., 2012), but do not acquire
FA to a great extent, nor have appreciable lipid droplets, we
wondered whether the localization of ER and mitochondria in
memory T cells suggested that lipids synthesized in the ER are
substrates for FAO. The electron-dense structures in IL-15mem-
ory T cells might indicate an abundance of synthesized lipid
from the ER in nutrient replete culture conditions, whereas in
memory T cells generated after infection, lipids might be meta-
bolized as they are made, thereby accounting for the absence
of these structures in memory T cells.
To assess lipid synthesis, we cultured IL-15 memory T and
IL-2 Teff cells with C75, an inhibitor of fatty-acid synthase
(FASN) (Hansen et al., 2013). Consistent with the idea that
IL-15 memory T cells synthesize FA for survival, IL-15 memory
T cell survival decreased when cultured with C75. At the same
concentration of C75, IL-2 Teff cell survival was unaffected,
although proliferation was attenuated (Figures 3A and 3B), sup-
porting that IL-2 Teff cells synthesize lipid for biomass (Wang
et al., 2011). However, higher concentrations of C75 reduced
IL-2 Teff cell survival (Figure S2A), consistent with a recent
finding that proliferating T cells defective in FA synthesis (FAS)
have decreased survival (Lee et al., 2014). We also attempted
to genetically block FAS by silencing ATP-citrate lyase (ACL),
an enzyme that generates cytosolic acetyl-CoA, a substrate
needed in FAS (Hatzivassiliou et al., 2005). IL-2 Teff cells trans-
duced with a retrovirus expressing shRNA against ACL (hpACL)
had no defect in survival, but had attenuated proliferation
compared to control shRNA IL-2 Teff cells (Figures S2B–S2D).
Unexpectedly, survival of hpACL IL-15 memory T cells was not
impaired (Figure S2B). These data are in contrast to the
decreased survival of IL-15 memory T cells cultured with C75.
This disparity could be due to two possibilities, both of which
center on the idea that metabolic and biosynthetic demands
are low inmemory T compared to Teff cells. Incomplete silencing
of ACL (Figure S2D) might result in enough acetyl-CoA produced
to support FAS needed for IL-15 memory T cell survival, but not
Immunity
Lysosomal Lipolysis in CD8+ Memory T Cellsfor the extensive proliferation of IL-2 Teff cells. Alternatively,
IL-15 memory T cells might be able to switch from using ACL
derived acetyl-CoA to that produced from acetate via acyl-
CoA synthetase, an effect previously observed after ACL dele-
tion (Hatzivassiliou et al., 2005; Zaidi et al., 2012). As C75 inhibits
FASN directly, these potential confounding factors are removed.
Therefore, the results using C75 indicate that despite IL-15
memory T cells having a more quiescent phenotype, these cells
are acutely sensitive to inhibition of FAS. Because IL-15 memory
T cells have a reduced demand for lipid for anabolic processes,
as well as reduced extracellular FA uptake, these cells likely use
synthesized lipids for catabolic processes such as FAO.
Most cells can synthesize lipid from glucose carbon that
enters the TCA cycle, which is exported from the mitochondria
as citrate (Vander Heiden et al., 2009) and is used for FAS
(Wakil et al., 1983). To explore whether memory T cells synthe-
size lipids from glucose, we cultured IL-2 Teff and IL-15 memory
T cells with 13C-labeled glucose and analyzed 13C-glucose
incorporation into the FA chains of PG and PE lipid via mass
spectrometry (MS). Both cell types synthesized lipids from
glucose; although the overall rate of glucose incorporation into
lipid was lower in IL-15memory T cells, a similar relative incorpo-
ration of 13C-glucose into these lipids occurred in IL-2 Teff and
IL-15 memory T cells (Figure S2E). Consistent with active lipid
synthesis, FASN, and acetyl-CoA carboxylase 1 and 2 mRNA,
were similarly expressed in both cell types (data not shown).
To explore whether IL-15 memory T cells use glucose to pro-
duce FA for OXPHOS, we assessed O2 consumption rates
(OCR, an indicator of OXPHOS) in cells cultured in normal media
(11 mM glucose) or media with low (2 mM) glucose (LG) (Fig-
ure 3C). The substantial spare respiratory capacity (SRC) prom-
inent in memory T cells (van der Windt et al., 2012) (OCR after
FCCP/basal OCR) was reduced in LG, indicating that in these
cells, glucose contributes to OXPHOS and maximal respiratory
capacity (Figure 3C). The precipitous reduction in SRC of cells
in LG is consistent with the view that glucose supports FAO,
as the majority of the SRC in glucose replete-media is derived
from long-chain FAO, indicated by the substantial reduction
in this parameter in the presence of etomoxir, a specific inhi-
bitor of carnitine palmitoyl transferase 1a (CPT1a), which
transports long-chain FA into the mitochondria and is a rate
limiting step of FAO (Figure 3C) (van der Windt et al., 2012).
IL-15 memory T cells in LG also had decreased basal OXPHOS,
indicating that glucose supports OXPHOS in the steady state.
A similar trend was detected when cells cultured in glucose-
replete media were subsequently transferred to LG right
before OCR was measured (data not shown), indicating that
the decreased OXPHOS in LG was not due to alterations in
mitochondrial mass that could occur in prolonged culture. In
cancer cells, glutamine provides an alternate carbon source
for lipid synthesis in LG (Le et al., 2012); however, we found
that excess glutamine did not rescue the defects in IL-15
memory T cell metabolism (Figure S2F). In contrast to IL-15
memory T cells in LG, OXPHOS in IL-2 Teff cells was not
impaired (Figure 3C). Consistent with published observations
(Buzzai et al., 2005), T cells cultured in IL-2 compensated
for reduced glycolysis in LG by increasing FAO supported
OXPHOS, as indicated by the reduction in OCR following
etomoxir in IL-2 Teff cells in LG.To support that memory T cells use glucose for FAO and
OXPHOS, we assessed glucose uptake in T cells by using the
fluorescent glucose analog 2-NBDG. On day 7 after infection
we compared Teff cells to Tn and memory T cells from mice in-
fected 1 month previously. We found that Tn and memory T cells
acquired more 2-NBDG than Teff cells (Figure 3D, bar graph).
This trend was also apparent in polyclonal T cells expressing
Tn, Teff, and memory T markers, when analyzed from a single
mouse at day 7 postinfection (Figure 3D, histogram). The
increased 2-NBDG uptake in these quiescent cells is consistent
with their use of glucose for survival. Importantly, although the
data showing that memory T and Tn cells acquire more 2-
NBDG than Teff are surprising, they do not argue against a role
for glucose and glycolysis in Teff cell proliferation or effector
function (Chang et al., 2013; Fox et al., 2005; Jacobs et al.,
2008; Wang et al., 2011). We find that early Teff cells, present
day 5 after Lm infection, when clonal expansion has yet to
peak, have higher ECAR than day 7 Teff cells (data not shown).
We speculate that the later day 7 Teff cells acquire less glucose
than early Teff cells, because late Teff cells are on the verge of
contraction, whereas early Teff cells, which are highly glycolytic,
are more similar to in vitro generated IL-2 Teff cells. This would
be in keeping with the fact that IL-2 Teff cells acquire more
2-NBDG than IL-15 memory T cells in vitro (Figure S2G). Also,
these data are not inconsistent with a recent paper showing
that restraining terminal differentiation of Teff cells in vitro by
treating with the glycolysis inhibitor 2-DG forms better memory
T cells in vivo (Sukumar et al., 2013), because 2-DG was
administered in the Teff phase, but not during memory T cell
development.
Because intracellular free FA can be toxic, most cells store
excess FA in less reactive forms, such as TAG, and then release
FA from these stores as needed (Thiam et al., 2013). To explore
whether synthesized TAG contributes to FAO in IL-15 memory
T cells, we inhibited diacylglycerol acyltransferases (DGAT) 1
and 2, critical enzymes for TAG synthesis, with the inhibitor
Amidepsine A (AmA) (Tomoda et al., 1995). IL-15 memory
T cells treated with AmA exhibited reduced SRC and were
insensitive to etomoxir (Figure 3E), indicating that these cells
were no longer using long-chain FA to fuel OXPHOS. This effect
was specific to IL-15 memory T cells, because AmA treated IL-2
Teff cells did not exhibit OXPHOS defects (data not shown).
To confirm that IL-15memory T cells synthesize lipids for FAO,
we cultured IL-15 memory T or IL-2 Teff cells in lipid-depleted
(LD) media. We observed no defect in basal OXPHOS, SRC, or
long-chain FAO in IL-15 memory T cells cultured in LD media
(Figure 3F). We did find reduced OXPHOS in IL-2 Teff cells
(Figure 3F), which was accompanied by decreased glycolysis
(data not shown), likely due to reduced availability of extracellular
lipids impairing anabolic processes and leading to an overall
reduction in metabolic activity in these cells. Collectively our
data indicate that IL-15 memory T cells synthesize lipids and
are not dependent on extracellular FA to fuel OXPHOS.
The Lipid Signature of Memory T Cells Suggests
Active Lipolysis
Most cells can store lipids as TAG and CE then subsequently
release FA from these stores when needed (Thiam et al., 2013).
Because we did not detect lipid droplets in memory T cells, weImmunity 41, 75–88, July 17, 2014 ª2014 Elsevier Inc. 79
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Figure 3. Glucose Fuels Mitochondrial FAO and OXPHOS in IL-15 Memory T Cells
(A) IL-2 Teff and IL-15 memory T cell survival (7-AAD exclusion) ± C75, shown as survival relative to vehicle (Veh.) treated cells. Data from five experiments show
mean ± SEM, **p < 0.01.
(B) IL-2 Teff proliferation in the presence of C75 or vehicle. Data represent three experiments.
(C) OCR of IL-2 Teff or IL-15 memory T cells cultured in TCM (Control) and low glucose TCM (LG) was measured under basal conditions and in response to
oligomycin (Oligo), FCCP, etomoxir (Eto), and rotenone + antimycin (Rot+Ant). Data represent two experiments shown as mean ± SEM.
(D) Representative plot (histogram) and averageMFI (bar graph) of 2-NBDG uptake in polyclonal Teff andmemory T cells from one experiment (n = 4mice/group).
Data in error bar show mean ± SEM, ***p < 0.001.
(legend continued on next page)
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Figure 4. The Lipid Signature of Memory
T Cells Suggests Active Lipolysis
(A–F) Lipids were quantified from day 7 cultured
IL-2 Teff and IL-15 memory T cells. Data represent
three experiments shown as mean ± SEM,
*p < 0.05.
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Lysosomal Lipolysis in CD8+ Memory T Cellsreasoned that they might oxidize fat shortly after its synthesis,
and any synthesized TAG could be quickly lipolyzed, for fuel.
This would agree with our data demonstrating that inhibiting
DGAT impairs FAO in IL-15 memory T cells. We next questioned
whether we could detect altered concentrations of lipid species
that are broken down during lipolysis in memory T cells. We
assessed the abundance of TAG, diacylglycerol (DAG), and
CE, which are targets of lipolysis. Relative abundance of choles-
terol, phosphatidylcholine (PC), and phosphatidylethanolamine
(PE) were similar between IL-15 memory T and IL-2 Teff cells
(Figures 4A–4C). However, consistent with active lipolysis, we
found that CE and DAG were significantly decreased in IL-15
memory T cells as compared to IL-2 Teff cells (Figures 4D and
4E). In contrast, TAG abundance was similar between these cells
(Figure 4F), perhaps suggesting that TAG is actively synthesized
in IL-15 memory T cells and was evident as the electron-dense
deposits between mitochondria and ER (Figure 2B). A trend
toward decreased neutral lipids was observed in memory T
compared to Teff cells after LmOVA infection, with significantly
reduced CE (Figure S3). Overall, the alterations in neutral lipids
in memory T cells support the idea that these species are hydro-
lyzed to provide FA for FAO.
Lysosomes Associate with Neutral Lipids in
Memory T Cells
While glucose-derived 13C incorporation into lipids indicated that
lipid synthesis occurs in IL-2 Teff and IL-15 memory T cells, the
differences in TAG, CE, and DAG suggested that lipolysis
actively occurs in memory T cells, which agrees with the fact
that they engage FAO (van der Windt et al., 2012). Because we
did not find evidence of adipocyte-like lipid droplets in memory
T cells (Figures 2A and 2B), we considered that their lipolytic
machinery might differ from those characterized in adipocytes,
such as that mediated by ATGL and HSL (Zechner et al.,
2012). LAL is a lipase capable of hydrolyzing TAG, DAG, and
CE to generate free FA and cholesterol in lysosomes (Sheriff
et al., 1995). We assessed its expression and found that LAL(E) OCR represented as percentage of baseline for IL-15 memory T cells cultured with AmA or vehicle (Contr
represent two experiments shown as mean ± SEM.
(F) OCR of IL-2 Teff or IL-15 memory T cells cultured in TCM (control) and lipid depleted TCM (LD), measured u
drugs. Data represent two experiments shown as mean ± SEM.
Immunity 41, 7protein and/or mRNA were increased in
IL-15 memory T and ex vivo memory
T cells when compared to Teff cells, as
were memory T cells when compared to
2 Teff cells (Figures 5A–5C; Figure S4).
We reasoned that if LAL regulates lipol-
ysis in memory T cells, colocalization of
neutral lipids and lysosomes might occurshortly after exposure to IL-15, when cells are differentiating
toward a memory T cell phenotype. IL-15 promotes FAO and
the memory T cell phenotype in these cells (Carrio et al., 2004;
van der Windt et al., 2012). We stained day 4-activated IL-2
Teff cells, and day 4 IL-15 early memory T cells (i.e., only 1 day
of exposure to IL-15), with Bodipy and LysoTracker, to visualize
neutral lipids and lysosomes, respectively. Confocal microscopy
revealed that lysosomes associated with neutral lipid in day 4
IL-15 memory T cells, but not in day 4 IL-2 Teff cells (Figure 5D).
In line with the idea that lysosome association with lipid would
lead to lipolysis and subsequent fueling of FAO, the neutral lipid
that was evident 1 day after exposure to IL-15 was nearly unde-
tectable after 3 days in culture with IL-15 (Figure 5E). This finding
is corroborated by data in Figure S5, showing that LAL mRNA
expression increased 1 day following IL-15 exposure, and signif-
icant reductions in DAG and CE were detected within 3 days.
These data support the hypothesis that memory T cells hydro-
lyze intracellular neutral lipid.
Lysosomal Lipolysis Metabolically Programs T Cells
toward the Memory T Cell Phenotype
We wondered whether LAL plays an important cell intrinsic role
in memory T cells. Mice deficient in LAL have defects in thymo-
cyte development and in maturation of peripheral T cells
(Qu et al., 2009). Given the defects in T cell development in
LAL-deficient mice, this model was not conducive to studying
LAL in memory T cells. We took a different genetic approach
and transduced activated T cells with a retrovirus expressing
either shRNA against LAL (hpLAL) or a control shRNA. This
allowed us to suppress the expression of LAL (Figures S6A
and S6B) after the T cells were activated. Neutral lipid was
increased in hpLAL IL-15 memory T cells compared to controls
(Figure 6A), and no increase was observed in hpLAL expressing
IL-2 Teff cells. These results suggest that LAL actively hydrolyzes
lipid in IL-15 memory T cells, and silencing LAL blocks lipolysis,
resulting in increased neutral lipid. To confirm that hpLAL spe-
cifically targets lipolysis, we measured TAG and CE in controlol) measured in response to indicated drugs. Data
nder basal conditions and in response to indicated
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Figure 5. Lysosomes Associate with Intracellular Neutral Lipids
during the Memory T Cell Transition In Vitro
(A) Relative mRNA expression of LAL in day 7 IL-2 Teff and IL-15 memory
T cells. Data from three experiments shown as mean ± SEM, ***p < 0.001.
(B) LAL protein expression compared to b-Actin. Data represent two experi-
ments.
(C) Relative mRNA expression of LAL in Teff and memory T cells. Data from
three experiments shown as mean ± SEM, *p < 0.05. IL-2 Teff and IL-15
memory T cells were stained with LysoTracker (blue) and Bodipy (green) on
day 4 (D) or day 7 (E) of culture. Scale bar represents 2 mM. Data represent
three experiments.
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species, indicating that lipolysis was blocked (Figure 6B).
Because IL-15 promotes FAO in T cells (van der Windt et al.,
2012), we investigated whether LAL-mediated lipolysis would82 Immunity 41, 75–88, July 17, 2014 ª2014 Elsevier Inc.provide FA for FAO in T cells after IL-15 exposure. As we
observed lysosomal association with neutral lipid soon after
IL-15 exposure, we expected that any effects on metabolism
should be detectable at this time. Therefore, 3 days after acti-
vation we exposed control or hpLAL transduced IL-2 Teff cells
to IL-15 and immediately analyzed OCR in real time. When
compared to hpLAL cells, control cells in IL-15 showed a pro-
gressive and substantial increase in OCR (Figures 6C and 6D).
The rapid but blunted increase in IL-15 induced OXPHOS in
the hpLAL T cells suggested that the residual amount of LAL
expressed (Figure S6A) is sufficient to metabolically reprogram
the cells toward lipolysis and FAO under memory T cell-inducing
conditions (i.e., IL-15 in the absence of IL-2) and that the induc-
tion of LAL expression by IL-15 is downstream of this process.
When cells were exposed to etomoxir, OCR dropped precipi-
tously, indicating that the increase in OXPHOS following IL-15
exposure was due to FAO. However, the magnitude of this
decrease in OCR was substantially reduced in hpLAL cells, indi-
cating that FAO-fueled OXPHOS is facilitated by LAL-mediated
lipolysis (Figures 6C and 6D).
As the initial increase in OCR appeared rapid in hpLAL cells
and at a slightly different kinetic from the control, it is also
possible that a different substrate is fueling OXPHOS shortly
after exposure to IL-15 in hpLAL cells, and that FAO only occurs
after a few hours, when respiration becomes etomoxir sensitive.
Because hpLAL cells remain more glycolytic, as indicated by
the increased extracellular acidification rate (ECAR) (Figure 6D),
the initial burst in OCR could be fueled by glucose oxidation
in the mitochondria. Further experiments will be needed to
determine whether this is the case. Regardless, the increase
in glycolysis also suggested that LAL inhibition impaired the
ability of T cells to metabolically transition toward a memory
T cell phenotype. Consistent with this idea, hpLAL IL-15 memory
T cells expressed increased CD25 and reduced CD62L com-
pared to control cells, indicating that hpLAL IL-15 memory
T cells retained a more activated phenotype (Figure 6E).
There is a strong link between FAO and CD8+ T cell longevity
(van der Windt et al., 2012). If LAL is important for FAO, reduced
LAL expression should limit survival of these cells when cultured
in IL-15. We found that while hpLAL IL-2 Teff cells exhibited no
survival disadvantage compared to controls, hpLAL IL-15 mem-
ory T cells exhibited a significant survival defect (Figure 6F). A
similar decrease in survival was also observed with IL-15
memory T cells, but not IL-2 Teff cells, when cultured with chlo-
roquine, which prevents LAL activity by inhibiting lysosome
acidification (Figure S6C) (Bowden et al., 2011). These results
indicate that LAL supports FAO in T cells and that lysosomal
lipolysis contributes to IL-15-mediated T cell survival in vitro.
We considered a role for ATGL in lipolysis in memory T cells,
despite the fact we could not detect classical lipid droplets in
these cells. We cultured activated CD8+ T cells from ATGL-defi-
cient mice (Pnpla2/) in IL-15 and found no differences in the
expression of T cell activation markers, neutral lipid content, or
survival when compared to wild-type CD8+ T cells (Figures
S7A and S7B). Likewise, we found no defect in memory T cell
development by Pnpla2/ OT-I cells following LmOVA infec-
tion (Figure S7C). These results support the hypothesis that
unlike ATGL, LAL has a predominant role in memory T cell
development.
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T Cell Development after Infection
To explore whether LAL, and thus T cell intrinsic lipolysis, sup-
ports Ag-specific CD8+ T cell survival in vivo after activation
signals are withdrawn, we transferred control or hpLAL trans-
duced congenic IL-2 Teff cells into C57BL/6 mice. The number
of hpLAL GFP+ donor cells recovered from the spleen and lymph
nodes (LN) 2 days later was dramatically lower than control cells,
indicating that LAL regulates the survival of activated CD8+
T cells in vivo after the withdrawal of activation signals (Figures
7A and 7B). We view this environment to be similar to what
occurs after infection, when pathogen is cleared, activation
signals wane, and Ag-specific Teff cells contract. To establish
that LAL is important for memory T cell development, we tracked
OVA-specific responses of control or hpLAL transduced OT-I
cells following immunization with LmOVA. To accomplish this,
we infected a congenically marked OT-I donor mouse and
C57BL/6 recipient mice with LmOVA. One day later, splenocytes
from the donor mouse were isolated, transduced, and then
transferred into the recipient mice. During the peak of the Teff
cell response (7 days postinfection), the percentage of control
and hpLAL cells (detectable by GFP expression) in the blood
were similar, despite efficient silencing of LAL (Figure 7C; Fig-
ure S6B). However, after contraction of the Ag-specific popula-
tions (26 days postinfection), the frequency of hpLAL GFP+ cells
was significantly less than control GFP+ cells, indicating that
hpLAL cells fail to form a robust CD8+ memory T cell population
(Figure 7C). Illustrating the defect in memory T cell development,
when the mice were challenged with LmOVA to induce a 2 Teff
cell response, the number of hpLAL GFP+ cells recovered from
the spleen was also significantly less than control GFP+ cells
(Figure 7D). Collectively, these results show that LAL regulates
CD8+ memory T cell development.
DISCUSSION
While our results show that cell intrinsic lipolysis supplies FA for
FAO in memory T cells, precisely which substrates T cells can
use to produce TAG for lipolysis, especially in vivo, is still under
investigation. At this time, we infer from our data that glucose
is used to synthesize TAG in these cells. We base this on our
observations that memory T cells do not acquire substantial
amounts of free FA and that glucose supports FAO andOXPHOS
in these cells in vitro. Regardless of which substrates these
cells use to produce TAG, our data show that the coupling of
TAG synthesis and subsequent FAO is how memory T cells
meet metabolic demands.
Futile metabolic cycling of FAS and FAO has been docu-
mented in muscle and adipose tissue (Dulloo et al., 2004; Guan
et al., 2002; Yu et al., 2002) and in cells overexpressing DGAT
(Liu et al., 2009). How this futile cycling occurs is an intriguing
question, as FAO and FAS pathways can negatively regulate
each other. For example, malonyl-CoA, a substrate for FAS, is
an allosteric inhibitor of CPT1a (McGarry et al., 1977). It remains
to be determined whether FAS and FAO occur simultaneously or
whether cells oscillate between periods of FAS and FAO. If the
former occurs, then a mechanism for preventing malonyl-CoA
inhibition of CPT1a would be needed. Perhaps cells can partition
FAS and FAO into separate areas, or rapidly utilize malonyl-CoAfor FAS, while inducing activity of CPT1a. Memory T cells ex-
press more CPT1a than Teff cells (van der Windt et al., 2012),
suggesting that higher concentrations of malonyl-CoA would
be needed for inhibition. However, oscillating cycles could also
occur if malonyl-CoA concentrations fluctuate, with higher
amounts resulting in CPT1a inhibition and increased FAS, and
with lower amounts, due to its consumption through FAS,
CPT1a inhibition would be relieved and FAO permitted. Although
the coupling of FAS and FAO is not energetically efficient in
terms of ATP production, and based on this notion is seemingly
paradoxical, it is possible that this process allows memory
T cells to preserve glycolytic and lipogenic machinery, while
maintaining mitochondrial health over long periods of quies-
cence, rendering these cells ‘‘primed and ready’’ to tap into their
substantial metabolic reserve required for rapid reactivation
following Ag recognition.
Relatively little is known about lipolysis or lipolytic mecha-
nisms in nonadipose tissues (Zechner et al., 2012). Our results
showing that Teff cells have the capacity to acquire external
FA and store excess in lipid droplets—whereas memory
T cells, which rely on FAO for survival, do not—were unexpected.
Most cell types are thought to be able to acquire and store
excess lipids (Thiam et al., 2013). It has been shown that regu-
latory T (Treg) cells in adipose tissue express CD36 and have
lipid droplets (Cipolletta et al., 2012), and that proliferating
T cells during graft versus host disease increase in FA uptake
(Byersdorfer et al., 2013). Although our data suggest that
memory T cells do not acquire excess exogenous FA to fuel
OXPHOS, more work is needed to determine why these T cells
have this unique phenotype. Perhaps memory T cells, or even
other long-lived immune cells, do not store lipid in lipid droplets
as a protective mechanism against viruses, which often use
these organelles as sites of replication and persistence (Camus
et al., 2013; Miyanari et al., 2007).
We initially hypothesized that because memory T cells use
FAO, these cells would acquire free FA as fuel, much like
in vitro Treg cells and other cells that engage FAO (Dhalla
et al., 1992; Kodde et al., 2007; Michalek et al., 2011; Zhang
et al., 2010). This idea would have fit with the fact that CD8+
memory T cells reside in lipid-rich niches, such as bone marrow
and LN. However, our findings that Teff, but not memory T cells,
acquire substantial amounts of FA raises the possibility that fat
around LN supplies substrate for rapidly dividing cells, such as
would be required during an immune response. Unlike other
cells in the body, lymphocytes divide extremely rapidly following
activation, and there could be an advantage to having substrates
‘‘on hand,’’ rather than depending on circulating lipids derived
from central stores. Although FA derived from lipolysis can fuel
OXPHOS, lipolysis is also required for the production of lipid
signaling molecules, such as lipid ligands that activate the
peroxisome proliferator-activated receptor (PPAR) pathway
(Haemmerle et al., 2011). Future studies are needed to illuminate
the precise destinies for all mobilized lipids in T cells.
The fact that we found no evidence that memory T cells form
classical lipid droplets agrees with the lack of a role for ATGL
in their survival. Our data suggest that memory T cells can syn-
thesize FA by using glucose-derived carbon, and we speculate
that these FA are converted to TAG in the ER, which in turn
directly undergo LAL-mediated lipolysis to generate FA forImmunity 41, 75–88, July 17, 2014 ª2014 Elsevier Inc. 83
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Figure 6. Lysosomal Lipolysis Metabolically Programs CD8+ T Cells toward the Memory T Cell Phenotype
IL-2 Teff or IL-15 memory T cells were transduced with retroviral vectors containing shRNA against luciferase (Control) or against LAL (hpLAL).
(A) Cells were stained for neutral lipids with Bodipy. Data represent three experiments.
(B) IL-15 memory T cells were analyzed for lipid content by MS. Data from three experiments show mean ± SEM, *p < 0.05, ***p < 0.001.
(C–E) On day 3 of culture, IL-2 Teff cells were washed and resuspended in media with IL-15. OCR and ECAR were measured. (C) Representative plot
showing OCR. (D) Relative change in OCR, ECAR, and OCR/ECAR 5 hr after baseline, represented as percent change from baseline. Data from five
(legend continued on next page)
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D
B Figure 7. T Cell Intrinsic Lysosomal Lipol-
ysis Supports CD8+Memory T Cell Develop-
ment after Infection
(A and B) Congenic IL-2 Teff cells were transduced
with control or hpLAL and sorted onGFP. On day 6
of culture, 2 3 106 cells/mouse were injected
i.v. and harvested from spleen or LN 2 days
later. Data represent three experiments, shown
as mean ± SEM, ***p < 0.001.
(C–E) Congenic OT-I control or hpLAL transduced
cells were transferred into mice infected 1 day
prior with LmOVA. (C and D) Blood was analyzed
for CD8, KbOVA, Thy1.1, and GFP. (C) Data shown
as shown as mean ± SEM percentage of total
CD8+ (line graph); representative plots show
percent GFP+ of Thy 1.1+ donor cells. Data
represent two experiments, *p < 0.05. (D) Mice
were challenged with LmOVA and 5 days later
CD8+ KbOVA GFP+ cells from spleen were quan-
tified. Data shown as mean ± SEM and represent
two experiments, **p < 0.01.
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lets in memory T cells, this suggests that lipolysis of TAG would
occur shortly after synthesis. Consistent with this model, EM re-
vealed close localization of ER and mitochondria in memory
T cells. More work is needed to confirm this mechanism and to
understand how lysosomes are involved in this process. Of
note, in parallel studies, we have found that cell intrinsic expres-
sion of LAL is essential for IL-4-driven macrophage alternative
activation (S.C.-C.H., data not shown), suggesting that LAL
has broadly assumed a role in coordinating cytokine (IL-4 or
IL-15)-induced increases in FAO.
It was shown that autophagy can regulate lipid metabolism,
where lipid droplets and autophagic components associate
during nutrient deprivation, leading to release of TAG (Singh
et al., 2009). A recent study has also connected lysosomalexperiments show mean ± SEM, *p < 0.05 or **p < 0.01. (E) Expression of CD25 and CD62L on day 7 IL-2
experiments.
(F) Day 3 IL-2 Teff cells were cultured in IL-2 or IL-15 and analyzed daily (days 0–4) for survival (7AAD exclusio
nontransduced cells. Data from three experiments are shown as mean ± SEM, **p < 0.01 by two-way ANOV
Immunity 41, 7lipolysis and autophagy to nutrient
availability, fat storage, and aging in
C. elegans (O’Rourke et al., 2013) and
showed that lysosomal lipolysis and
autophagy are transcriptionally linked
to nutrients in mammals. Future studies
delineating autophagy and lipolysis in
memory T cell development and how
nutritional status orchestrates these
pathways to control cellular lifespan
are needed. It has also been shown
that the transcription factor forkhead
homeobox type protein O1 (FoxO1) is
induced by nutrient restriction in adipo-
cytes and exerts transcriptional control
of lipid catabolism via the induction of
LAL (Lettieri Barbato et al., 2013). Givenseveral papers showing the importance of FoxO1 in the devel-
opment of memory T cells (Rao et al., 2012; Tejera et al.,
2013), it is possible that this factor promotes memory T cell
development by promoting lipolysis. Our preliminary results
indicate that inhibiting the activity of FoxO1 in IL-15 memory
T cells blocks LAL mRNA expression. It has also been shown
that metformin, a drug used to treat type 2 diabetes, elicited
FoxO1-dependent LAL induction and lipophagy in adipocytes
(Lettieri Barbato et al., 2013). These results complement our
previous findings that metformin promotes FAO in memory
T cells and enhances their development in vivo (Pearce
et al., 2009). Understanding how lipid metabolic programs
are enacted in T cells and how these programs can be manip-
ulated to increase cell longevity will be a subject of future
study.Teff or IL-15 memory T cells. Data represent five
n). Data represented as percent survival relative to
A.
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See the Supplemental Information for details.
Mice and Immunizations
C57BL/6, C57BL/6-Tg (TcraTcrb)1100Mjb/J (OT-I), B6.129P2-Pnpla2tm1Rze/J
(Pnpla2/), and OT-I CD90.1 mice were maintained at Washington University
School of Medicine under protocols approved by the Institutional Animal
Care andUseCommittee. L. monocytogenes deficient for actA and expressing
OVA (LmOVA) was used for infections.
Cell Culture
T cell media (TCM) contained RPMI 1640 with 10% FCS, 2 mM L-glutamine,
100 U/ml Pen Strep, and 55 mM 2-Me. LG TCM contained 2 mM glucose,
and excess glutamine was added (8 mM) as indicated. LD TCM contained
FCS depleted of lipids with PHM-L Liposorb. For drug cultures, 10 mM chloro-
quine, 20 or 40 mM C75, 20 mM AmA, or respective vehicles (H2O or DMSO)
were added on day 3 of culture. For oleate cultures, cells were incubated
overnight in TCM ± 100 mM oleate conjugated to bovine serum albumin.
Flow Cytometry and Microscopy
OVA-specific CD8+ T cells were quantified with H2-KbOVA257–264 (K
bOVA)
MHC-peptide tetramers. To identify neutral lipids, we stained cells with
500 ng/ml Bodipy 493/503. For lipid uptake, in vitro or ex vivo cells were
incubated with either 1 mM Bodipy FL C16 or 10 mg/ml Bodipy FL LDL in
TCM. For Bodipy FL C16 uptake, in vivo mice were injected intravenously
(i.v.) with 50 mg/mouse diluted in DPBS. For 2-NBDG uptake in vivo, mice
were injected i.v. with 100 mg/mouse diluted in DPBS or in vitro: cells were
incubated in media containing 50 mg/ml 2-NBDG. For transmission EM, cells
were fixed in 2% paraformaldehyde 2.5% glutaraldehyde in 100 mM sodium
cocodylate containing 0.05% malachite green.
Retroviral Transduction
Activated OT-I splenocytes were transduced with human CD8 or GFP ex-
pressing control (virus expressing shRNA against luciferase), hpLAL (virus
expressing shRNA aganst LAL), or LD-GFP (virus expressing the sequence
of the 38 AA N-terminal of METTL7B fused to eGFP).
Adoptive Transfers
For in vivo memory T cell experiments, donor and recipient mice were infected
i.v. with 5 3 106 cfu of LmOVA. The following day, splenocytes from donor
mice were transduced with control or hpLAL. Following transduction, cells
were injected i.v. (5 3 105 CD8+ cells/mouse) into recipient mice. For in vivo
survival experiments, OT-I cells transduced with control or hpLAL and sorted
on GFP expression. On day 6 of culture, 2 3 106 CD8+ cells/mouse were
injected i.v into naive C57BL/6 mice.
Metabolism Assays
Cells were plated in XF media ± 10% FCS added as indicated. For LG condi-
tions, 2 mM glucose XF media was prepared ± L-glutamine (8 mM) as indi-
cated. For LD conditions, XF media was prepared without FCS. OCR and
ECAR were measured under basal conditions and following the addition of
IL-15 (10 ng/ml) or the following drugs: 1 mM oligomycin, 1.5 mM FCCP,
200 mM etomoxir, and 100 nM rotenone + 1 mM antimycin A with an Extracel-
lular Flux Analyzer.
Lipidomics and Glucose Tracing
For glucose tracing, cells were cultured into IL-2 Teff and IL-15 memory T.
On day 6, cells were cultured for 24 hr in TCM containing only D-[U-13C]
labeled glucose and analyzed by MS.
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